About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

OPTImization of Inflammatory Bowel Disease Treatment Through Understanding of Gut VIRome Heterogeneity

NCT07240181·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Andreas M Petersen, Professor
CONTACT
+4538626199 andreas.munk.petersen@regionh.dk

Lead

Andreas Munk Petersen

With

University of Copenhagen

Age

18–any

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Confirmed diagnosis of UC, CD, or PSC-IBD for at least 6 months
Age ≥ 18 years
Stable medical treatment for IBD (and PSC-IBD) within the past 3 months
Stable lifestyle within the past month (including diet, exercise, and sleep habits)
Verbal and written informed consent

You may not be if

Use of antibiotics within the past 3 months
Pregnancy or breastfeeding
Substance abuse or excessive alcohol consumption (according to Danish Health Authority guidelines)
Other known comorbidities that may affect the gut microbiome (e.g., type 1 diabetes, other autoimmune diseases, cancer, severe obesity, etc.)

The record

StatusNot yet recruiting

PhaseNo phase

Taking part40

StartedDec 2025

UpdatedNov 20, 2025

Conditions

IBD (Inflammatory Bowel Disease)Crohns Disease Colitis Ulcerative

Where1

Hvidovre Hospital
Hvidovre, Denmark